Seattle researchers to engineer kidney tissue chip for predicting drug safety

July 25, 2012 By Leila Gray
Seattle researchers to engineer kidney tissue chip for predicting drug safety
An example of a tissue chip for drug safety testing. Credit: NCATS

(Medical Xpress) -- Seattle researchers will be part of the new federal initiative to engineer 3-dimensional chips containing living cells and tissues that imitate the structure and function of human organs.  These tissue chips will be used for drug safety testing.

Tissue chips merge techniques from the computer industry with those from bioengineering by combining miniature models of living organ tissues onto a transparent microchip. Ranging in size from a coin to a house key, the chips are lined with living cells and contain features designed to replicate the complex biological function of a specific organ.

The Seattle team will design, implement and test a tissue-engineered human kidney microphysiological system.  Kidneys, which clear the blood of waste products, are among the sensitive organs that can be damaged by certain medications, environmental toxins or an excess of natural substances produced by the body.

The Seattle project, announced July 24, is led by Dr. Jonathan Himmelfarb, University of Washington professor of medicine in the Department of Medicine, Division of Nephrology, and director of the Kidney Research Institute.  The project team consists of physicians, bioengineers, pharmacists, environmental health researchers, and pharmaceutical developers from the UW schools of medicine, public health and pharmacy, and the College of Engineering. The amount  and years of of funding to the UW are yet to be announced, pending Notice of Grant Award. Overall, the national initiative is budgeted at $70 million.

Their project proposal is one of 17 nationwide funded in a recent round of awards from the new National Center for Advancing Translational Sciences of the National Institutes of Health.  This grant program, a collaboration with the Defense Advanced Research Projects Agency and the U.S. Food and Drug Administration, was created to improve methods for predicting whether newly developed drugs will be safe in humans.

The goal is to develop human tissue chips that simulate  the structure and function of human organs, such the lung, heart, liver, and kidneys.  Scientists could then use these tissue chips to test drug candidates and predict their safety before the next step, human drug studies. This approach is expected be more rapid and cost effective than those currently available.

The NIH pointed to studies that show that more than 30 percent of promising medications have failed in human clinical trials because the drugs were found to be toxic, despite pre-clinical studies in animal models. Tissue chips may offer more accurate predictions of the side effects of potential therapeutic agents because they contain human cells.

Ten of the 17 new awards will support studies to design 3-dimensional cellular microsystems that represent different . These bioengineered devices will produce relevant physiological functions and will reflect the complexity and diversity of living organs, including genetic differences, disease complexity and pharmacological responses.  The additional seven National Center for Advancing Translational Sciences awards will explore the potential of stem cells and progenitor cells to form the many cell types that make up the architecture of complex organs. These could be a source of cells to populate tissue chips.

Himmelfarb and his colleagues propose to create a tiny, 3-dimensional lab device containing engineered biological tissues that will perform certain actions of a living human kidney.  The system would evaluate the uptake, breakdown and elimination of potentially toxic substances, and predict the rate for these chemical reactions. The system might also help assess kidney injury from infections disease organisms and from toxins, both those introduced into the body and those produced by the body.

The micro-model of kidney physiology will also feature two parallel structures – small blood vessels and the surface lining of the renal tubules.  This aspect of the device will enable researchers to study the complex interactions between these two structures, which are normally in intimate association inside each of the functional units of the kidney, the nephrons.

In addition to Himmelfarb, the UW project team includes Jeremy Duffield from the Department of Medicine, Division of Nephrology; Ying Zheng from the Department of Bioengineering; Ken Thummel and Joanne Wang from the Department of Pharmaceutics; David Eaton, of the Department of Environmental and Occupational Health and the UW Center for Ecogentics and Environmental Health, and Danny Shen from the Department of Pharmacy.

Nortis Inc., a bioengineering start-up company funded through  the UW’s Center for Commercialization, will also be a partner in the project. Thomas Neumann is president and CEO of Nortis.  Project plans include using the Life Sciences Development Fund-supported Washington Phenotype Biospecimen Resource to obtain specimens for the project.

Explore further: Lab-engineered kidney project reaches early milestone

Related Stories

Lab-engineered kidney project reaches early milestone

June 21, 2012
Regenerative medicine researchers at Wake Forest Baptist Medical Center have reached an early milestone in a long-term project that aims to build replacement kidneys in the lab to help solve the shortage of donor organs.

Success in growing functional pituitary gland in a lab culture will advance regenerative medicine

March 2, 2012
Embryonic stem cells grown in a laboratory culture can organize themselves into a partial pituitary gland that is fully functional when transplanted into mice, a team of researchers led by Yoshiki Sasai of the RIKEN Center ...

Scientists produce eye structures from human blood-derived stem cells

March 14, 2012
(Medical Xpress) -- For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.